After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CRMD falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of CorMedix Inc is $948.19M. A total of 2.52 million shares were traded on the day, compared to an average of 1.89M shares.
In the most recent transaction, Mistry Erin bought 1,500 shares of CRMD for 9.99 per share on Oct 31 ’24. After the transaction, the EVP, Chief Commercial Officer now owns 52,011 company shares. In a previous transaction on Nov 14 ’24, Hurlburt Elizabeth sold 140,027 shares at 11.18 per share. CRMD shares that EVP owns now total 45,397.
Among the insiders who bought shares, Hurlburt Elizabeth acquired of 140,027 shares on Nov 14 ’24 at a per-share price of $11.12.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CRMD has a high of $13.85 and a low of $3.61.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRMD is Buy with a score of 4.67.
